Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cris Dos Remedios

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Muscle Research and Cell Motility|January 14, 2009
Myofilament dysfunction in cardiac disease from mice to menNazha Hamdani, Monique de Waard, Andrew E Messer, et al.
Circulation Research|October 7, 2006
Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscleNadiya A Narolska, Nicoletta Piroddi, Alexandra Belus, et al.
International Journal of Cardiology|November 12, 2021
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progressionRoua Hassoun, Heidi Budde, Saltanat Zhazykbayeva, et al.
Journal of the American Heart Association|June 5, 2014
Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertensionSilvia Rain, Denielli da Silva Goncalves Bos, M Louis Handoko, et al.
International Journal of Cardiology|September 13, 2021
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathyRoua Hassoun, Heidi Budde, Saltanat Zhazykbayeva, et al.
Circulation. Heart Failure|January 12, 2021
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic CardiomyopathyMaike Schuldt, Jiayi Pei, Magdalena Harakalova, et al.
Cardiovascular Research|May 16, 2013
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathyE Rosalie Witjas-Paalberends, Nicoletta Piroddi, Kelly Stam, et al.
Cardiovascular Research|May 20, 2014
Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutationsE Rosalie Witjas-Paalberends, Ahmet Güçlü, Tjeerd Germans, et al.
Circulation|September 24, 2013
Right ventricular diastolic impairment in patients with pulmonary arterial hypertensionSilvia Rain, M Louis Handoko, Pia Trip, et al.
Circulation Research|March 20, 2013
Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutationsVasco Sequeira, Paul J M Wijnker, Louise L A M Nijenkamp, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Muscle Research and Cell Motility|January 14, 2009
Myofilament dysfunction in cardiac disease from mice to menNazha Hamdani, Monique de Waard, Andrew E Messer, et al.
Circulation Research|October 7, 2006
Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscleNadiya A Narolska, Nicoletta Piroddi, Alexandra Belus, et al.
International Journal of Cardiology|November 12, 2021
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progressionRoua Hassoun, Heidi Budde, Saltanat Zhazykbayeva, et al.
Journal of the American Heart Association|June 5, 2014
Protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertensionSilvia Rain, Denielli da Silva Goncalves Bos, M Louis Handoko, et al.
International Journal of Cardiology|September 13, 2021
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathyRoua Hassoun, Heidi Budde, Saltanat Zhazykbayeva, et al.
Circulation. Heart Failure|January 12, 2021
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic CardiomyopathyMaike Schuldt, Jiayi Pei, Magdalena Harakalova, et al.
Cardiovascular Research|May 16, 2013
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathyE Rosalie Witjas-Paalberends, Nicoletta Piroddi, Kelly Stam, et al.
Cardiovascular Research|May 20, 2014
Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutationsE Rosalie Witjas-Paalberends, Ahmet Güçlü, Tjeerd Germans, et al.
Circulation|September 24, 2013
Right ventricular diastolic impairment in patients with pulmonary arterial hypertensionSilvia Rain, M Louis Handoko, Pia Trip, et al.
Circulation Research|March 20, 2013
Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutationsVasco Sequeira, Paul J M Wijnker, Louise L A M Nijenkamp, et al.
Pageof 6